Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.

Baldwin MR, Jones AE, Zhang D, Gurung C, Khan Z, Saqi A, Yang X, Wei Y, Nandakumar R, Murphy SO, McGroder CF, Shaikh F, Arcasoy S, Benvenuto L, Grewal H, Smith BM, Hoffman EA, Yuen AC, Johal P, Carlsten C, Ryerson CJ, Richards JB, Wong AW, Nakanishi T, Shah AS, Garcia CK

Open source

DOI: 10.1172/jci.insight.199983
Published: 2026 Jul 8
Container: JCI insight
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.199983,
  title = {Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.},
  author = {Baldwin MR and Jones AE and Zhang D and Gurung C and Khan Z and Saqi A and Yang X and Wei Y and Nandakumar R and Murphy SO and McGroder CF and Shaikh F and Arcasoy S and Benvenuto L and Grewal H and Smith BM and Hoffman EA and Yuen AC and Johal P and Carlsten C and Ryerson CJ and Richards JB and Wong AW and Nakanishi T and Shah AS and Garcia CK},
  year = {2026},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.199983},
  url = {https://doi.org/10.1172/jci.insight.199983}
}

RIS

TY  - JOUR
TI  - Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.
AU  - Baldwin MR
AU  - Jones AE
AU  - Zhang D
AU  - Gurung C
AU  - Khan Z
AU  - Saqi A
AU  - Yang X
AU  - Wei Y
AU  - Nandakumar R
AU  - Murphy SO
AU  - McGroder CF
AU  - Shaikh F
AU  - Arcasoy S
AU  - Benvenuto L
AU  - Grewal H
AU  - Smith BM
AU  - Hoffman EA
AU  - Yuen AC
AU  - Johal P
AU  - Carlsten C
AU  - Ryerson CJ
AU  - Richards JB
AU  - Wong AW
AU  - Nakanishi T
AU  - Shah AS
AU  - Garcia CK
PY  - 2026
JO  - JCI insight
DO  - 10.1172/jci.insight.199983
UR  - https://doi.org/10.1172/jci.insight.199983
ER  -

APA

MR, B., AE, J., D, Z., C, G., Z, K., A, S., X, Y., Y, W., R, N., SO, M., CF, M., F, S., S, A., L, B., H, G., BM, S., EA, H., AC, Y., P, J., C, C., CJ, R., JB, R., AW, W., T, N., AS, S., & CK, G. (2026). Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.. JCI insight. https://doi.org/10.1172/jci.insight.199983

Source records

pubmed · retrieved 2026-09-26T09:42:26.145Z